Skip to main content
. Author manuscript; available in PMC: 2021 May 27.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Oct 4;273(3):516–523. doi: 10.1016/j.taap.2013.09.022

Table 6.

Multiple logistic regression (OR and 95% CI) in adult participants in NHANES.a

Participants, (% + SE)b Normal Overweight Obese

NHANES 1999–2006; n = 15899 5060 5594 5245
 BLL quartile 1 (≤1.00 μg/dL) 25.0 (0.72) 1 (reference) 1 (reference) 1 (reference)
 BLL quartile 2 (1.01–1.59 μg/dL) 24.5 (0.47) 1 (reference) 1.04 (0.87–1.25) 0.76 (0.66–0.87)
 BLL quartile 3 (1.60–2.39 μg/dL) 25.0 (0.55) 1 (reference) 1.02 (0.87–1.19) 0.66 (0.56–0.77)
 BLL quartile 4 (≥2.40 μg/dL) 25.5 (0.54) 1 (reference) 0.79 (0.65–0.95) 0.42 (0.35–0.50)
NHANES 1999–2002; n = 7764 2530 2783 2451
 BLL quartile 1 (≤0.70 μg/dL) 21.8 (0.82) 1 (reference) 1 (reference) 1 (reference)
 BLL quartile 2 (0.71–1.09 μg/dL) 22.6 (0.70) 1 (reference) 1.03 (0.78–1.36) 0.76 (0.60–0.96)
 BLL quartile 3 (1.10–1.60 μg/dL) 26.9 (0.66) 1 (reference) 0.94 (0.77–1.14) 0.62 (0.48–0.79)
 BLL quartile 4 (≥1.61 μg/dL) 28.7 (0.69) 1 (reference) 0.73 (0.58–0.93) 0.39 (0.30–0.52)
NHANES 2003–2006; n = 8135 2530 2811 2794
 BLL quartile 1 (≤0.70 μg/dL) 28.2 (1.12) 1 (reference) 1 (reference) 1 (reference)
 BLL quartile 2 (0.71–1.09 μg/dL) 26.1 (0.63) 1 (reference) 1.04 (0.81–1.33) 0.77 (0.65–0.90)
 BLL quartile 3 (1.10–1.60 μg/dL) 23.2 (0.82) 1 (reference) 1.11 (0.88–1.39) 0.74 (0.60–0.90)
 BLL quartile 4 (≥1.61 μg/dL) 22.5 (0.84) 1 (reference) 0.85 (0.64–1.12) 0.47 (0.37–0.59)
a

Adjusted for race/ethnicity, gender, age, hematocrit, smoking status, serum cotinine, alcohol consumption, education, calorie intake and moderate and vigorous activity covariates.

b

Percentages are sample-weighted for applicability to the U.S. population.